MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Clinical features"

  • 2025 International Congress

    Juvenile parkinsonism masquerading as hereditary spastic paraplegia

    I. Sarac, H. Sarac, F. Borovecki, J. Vukoja, K. Zic, I. Kresic (Zagreb, Croatia)

    Objective: To present a patient with juvenile parkinsonism initially presented with billateral foot dystonia and inreased deep tendon reflexes. Background: Patients with juvenile parkinsonism may…
  • 2025 International Congress

    The Burden of Spasticity in Adults with Cerebral Palsy in South Africa

    M. Noble, D. Veliotes, C. Dafkin (Parktown, South Africa)

    Objective: Describe the demographic profile of adults with Cerebral Palsy (CP) in South Africa (SA).Quantify the burden of spasticity in adults with CP.Investigate current spasticity…
  • 2025 International Congress

    Patient-reported Symptoms and their Impact in Hereditary Spastic Paraplegia and Spastic Ataxias

    M. Ademi, C. Dubec-Fleury, J. Morales Saute, J. Greenfield, R. Wallis, C. Gobeil, L. Renna Linton, A. Nadke, R. Horvath, F. Santorelli, B. de Warrenburg, M. Synofzik, S. Du Montcel, P. Consortium, R. Schüle (Heidelberg, Germany)

    Objective: To understand health impacts relevant to patients with hereditary spastic paraplegia (HSP) and spastic ataxia (SPAX) by determining the prevalence and relative importance of…
  • 2024 International Congress

    Ultrasound Assessment of Collagen Content in Contracted and Non-contracted Muscle Areas: A Comparative Study

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The objective of this study was to evaluate the feasibility and reliability of ultrasound imaging as a method to estimate collagen content in contracted…
  • 2024 International Congress

    Mutation of the ATP5F1A gene associated with dystonia, spasticity, myoclonus, cognitive impairment and epilepsy – a rare case report of a patient

    M. Danis, G. Krastev, J. Necpal, R. Jech, M. Zech (Trnava, Slovakia)

    Objective: We present a patient with generalized dystonia with spasticity, craniofacial dysmorphism and myoclonus on the left upper limb due to mutation of the ATP5F1A…
  • 2024 International Congress

    Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy

    HJ. Kim, HJ. Ha, CY. Lee, JY. Yun (Seoul, Republic of Korea)

    Objective: Introduction: Leukodystrophies are primarily known as childhood diseases, but recent advances in genetic testing and brain imaging have led to an increase in reports…
  • 2024 International Congress

    Phenotypic spectrum and natural history of POLR3A-associated spastic ataxia

    E. Jung, J. Infante, S. Satolli, F. Santorelli, M. Minnerop, S. Klebe, B. Warrenburg, J. Muñoz, A. Fellner, J. de Winter, A. O'Connor, J. Baets, S. Murphy, M. Ruiz Sales, A. Pujol Onofre, L. Ruggiero, G. Coarelli, A. Dürr, X. Kobeleva, C. Stendel, T. Klopstock, F. Nicita, E. Bertini, Q. Thomas, Y. Goldberg, E. Kogan, L. Basel-Salmon, A. Lossos, Z. Argov, A. de Munain, L. Schöls, R. Schüle (Heidelberg, Germany)

    Objective: To foster trial-readiness, we delineate the full phenotypic spectrum and provide piloting longitudinal natural progression data of POLR3A-associated spastic ataxia in a large international cohort.…
  • 2024 International Congress

    Comparison in Therapeutic Outcome of Ultrasound-Guided Botulinum Injections for Limb Spasticity Versus Dystonia

    G. Yahalom, M. Cohen, I. Israel, R. Eichel, Y. Schechter (Jerusalem, Israel)

    Objective: To compare the therapeutic efficacy of BT injections for spasticity and dystonia in the limbs. Background: Botulinum toxin (BT) shows promise in alleviating limb…
  • 2024 International Congress

    The Clinical and Genetic Characteristics of HSP Patients by WES Sequencing Combined with MLPA

    YW. Cao, HR. Zheng, ZY. Zhu, L. Yao, WT. Tian, L. Cao (Shanghai, China)

    Objective: We aim to clarify the phenotype and gene spectrum of hereditary spastic paraplegia (HSP) and improve the molecular diagnosis. Background: Next-generation sequencing-based molecular assessment…
  • 2024 International Congress

    Clinical and Genetic Characteristics in a Chinese Cohort of Complex Spastic Paraplegia Type 4

    L. Yao, YW. Cao, C. Zhang, XJ. Huang, WT. Tian, L. Cao (shanghai, China)

    Objective: To delineate the genotypic and phenotypic spectrum of patients with complex SPG4 phenotype and further explore genotype-phenotype correlations. Background: Spastic paraplegia type 4 (SPG4),…
  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley